[ XXXX : Clinical evaluation of the severity and psychopathological profile].

@entity1 @entity239 @entity66 @entity915 @entity148 @entity18212 @entity1118
INTRODUCTION AND OBJECTIVE: @entity18212 ( @entity18212 ) is a @entity66 of controversial etiology, affecting some subjects when exposed to chemicals at no harmful concentrations. The objective of this paper is to describe the epidemiological, clinical and psychological features of a sample of @entity1 with @entity18212 for further specific group treatment. PATIENS AND METHOD: Descriptive study of @entity1 diagnosed with @entity18212 in a toxicology unit. We administered the Quick Environmental Exposure and Sensitivity Inventory, the structured interview @entity915 -II, the @entity148 scale HAS and the type A personality test, PCTA. RESULTS: Seventy-three @entity1 were included. The mean age was 52,6 years (range 33-77; SD 9.29). Sixty-six were females (90.4%). Fifty-three percent were classified as i-ii and ii grade. Sixty-one @entity1 (83%) presented some type of comorbidity, mainly @entity1118 , @entity239 and chronic fatigue. They exhibited higher levels of @entity148 (average score of 19.2), prevalence of phobic-avoidant traits of personality and type A behavior in 31.1%. CONCLUSIONS: @entity18212 affects middle-aged @entity1 with comorbidities ( @entity1118 , @entity239 and chronic fatigue) and high @entity148 and avoidance behaviors. This preliminary analysis should help provide a specific therapeutic approach to these @entity1 .
